News

EIT food impact funding framework call now open

Published on | 2 weeks ago

Programmes Agro-Food, Environment EIT

The European Institute for Innovation and Technology (EIT) tries to build the bridge between promising innovations and succesful start-ups. To this purpose they give guidance and financial assistance to aspiring entrepreneurs. One of the instruments of the subdivision EIT food is the Impact Funding Framework for which the sixth call for proposals was recently launched. 

The call consists of two parts. One financial instrument is aimed at collaborative proposals while the other one focuses at single project funding. 

The collaborative project should be situated in one these 3 key areas

  • Improve the impact of diet on obesity and non-communicable disease
  • Reduce food-system-related environmental harms
  • Deal with the threats posed by food integrity and complex supply chains

The 3 main topics of the single projects are as follows:

  • Protein Diversification: Bringing protein diversification to the mainstream
  • Regenerative Agriculture: Enabling farmers to lead the transition to Net Zero
  • Labelling, Packaging & Transparency: Empowering people in their food choices

The full details of the calls and an explanatory webinar can be found on this website

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1629 articles available search in articles 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.